Cambrex Corp (NYSE:CBM)

CAPS Rating: 4 out of 5

A life sciences company provides products and services that accelerate and improve the discovery and commercialization of human therapeutics.

Results 1 - 6 of 6

Recs

0
Member Avatar Reddragyn (67.47) Submitted: 5/21/2013 5:50:46 AM : Outperform Start Price: $12.99 CBM Score: -2.83

IMF

Recs

0
Member Avatar naylorj (28.19) Submitted: 7/17/2012 6:45:04 PM : Outperform Start Price: $9.38 CBM Score: +11.99

EPS Ranking 76

Recs

0
Member Avatar XCS (49.51) Submitted: 8/10/2011 12:37:41 PM : Outperform Start Price: $4.85 CBM Score: +112.18

A solid player among the small caps in this industry. Look for stock price increase as US corporare tax structure is stabilized over the next few years.

Recs

0
Member Avatar Maribaza (60.52) Submitted: 2/11/2011 12:23:10 PM : Underperform Start Price: $5.95 CBM Score: -85.06

Caps Most up

Category      Personal Score
Growth Rates %      Very Low
Price Ratios      High
Profit Margins %      High
Financial Condition      High
Investment Returns %      High
Management Efficiency      High
Total Score      Very Low

Recs

0
Member Avatar kalmia11 (< 20) Submitted: 4/14/2007 11:54:48 PM : Outperform Start Price: $11.64 CBM Score: -12.43

$14/share dividend on May 4

Recs

1
Member Avatar CycleFreak7 (< 20) Submitted: 2/23/2007 9:20:00 AM : Outperform Start Price: $10.63 CBM Score: -2.84

Reading EPS100Momentum's blog led me to CBM and the news of the company's intent to distribute a large dividend of $13.50 - $14.50 at an unspecified date in the future.

After watching SMG on the news of it's special one-time $8 dividend, there can be little doubt that CBM will appreciate considerably as the record date for the dividend approachs.

Results 1 - 6 of 6

Featured Broker Partners


Advertisement